David J. Adams is an Honorary Professor, Molecular Horizons/Faculty of Science, Medicine and Health, University of Wollongong, Australia (2025- 2028). He is also Chair of the Research Committee and Board Director of MND Australia and Senior Editor, British Journal of Pharmacology. He is a Fellow of the Australian Academy of Science (FAA), the Australian Academy of Health and Medical Sciences (FAHMS), the Royal Society NSW (FRSN), the American Physiological Society (FAPS), The Physiological Society UK (FTPS), and the International Union of Physiological Sciences Academy (FIUPS). He was previously a Distinguished Professor, University of Wollongong (2019-2024), CEO and Executive Director of the Illawarra Health & Medical Research Institute (IHMRI), University of Wollongong (12/2015-11/2022), Professor and Director of the Health Innovations Research Institute, RMIT University, Melbourne (9/2009-12/2015) and an ARC Australian Professorial Fellow (2010-2014) and during the period 04/2013-02/2014 he was Acting Deputy Vice-Chancellor (Research & Innovation) and Vice-President, RMIT University. He was Professor and Chair of Physiology at the University of Queensland (UQ; 1995-2009), Head of Department of Physiology & Pharmacology (1997-2000), Head of the School of Biomedical Sciences (2000-2007) and Professorial Research Fellow & Director of UQ Neuroscience Program, Queensland Brain Institute (2008-2009). He was appointed Assistant Professor, Department of Pharmacology, University of Miami School of Medicine, Miami, FL USA in 1984, promoted to Associate Professor (tenured) in 1989 and to full Professor in 1993.